AzTrials
AzTrials

Research institution

University Hospital, Toulouse Clinical Trials

Studies where University Hospital, Toulouse is the lead sponsor: what is enrolling now, by phase, condition and country.

805 registered studies

In numbers

Open to volunteers
177
Active
186
With results posted
2
All registered
805

Open to volunteers: recruiting, not yet recruiting or enrolling by invitation. Active adds studies under way that have stopped recruiting.

Open to volunteers

All 177
  • Hypotension

    Norepinephrine in the Management of General Anesthesia-Induced Arterial Hypotension in Chronic Heart Failure Patients

    • Recruiting
    • Age: 18 years and older
    • Observational study

    Arterial hypotension is a frequent complication of general anesthesia and a significant contributor to postoperative complications.

    Trial name
    NORAFLOW (NCT06350929)
    Testing
    Cardiac output monitoring by the Starling™ SV Sebac®
    Where
    France
    Volunteers
    50 people
    Sponsor
    University Hospital, Toulouse
    Can I take part? NORAFLOW
  • Endometriosis, Infertility

    Endometriosis Transcriptomic Cell Atlas

    • Recruiting
    • Age: 18 to 45 years
    • Surgery or procedure

    Endometriosis is an estrogen-dependent, chronic inflammatory gynecologic disease affecting women of reproductive age, with a therapeutic wandering of 6 to 10 years.

    Trial name
    EDISON (NCT06502548)
    Testing
    Endometriosis, Tubal ligation or Hysterectomy
    Where
    France
    Volunteers
    92 people
    Sponsor
    University Hospital, Toulouse
    Can I take part? EDISON
  • Prostate Cancer - Recurrent, Prostate Cancer (Diagnosis)

    Analysis of the Performance of PSMA Emission Tomography in Patients With Prostate Cancer Treated With HIFU

    • Not yet recruiting
    • Age: 70 years and older
    • Phase 4
    • Injection or infusion

    There would appear to be a strong interest in functional nuclear imaging for assessing the response to focal PaC treatment. Investigator team hypothesise that the diagnostic performance of PSMA PET is noninferior to that of MRI…

    Trial name
    ECETEP (NCT07766122)
    Testing
    Nuclear imaging (PSMA PET) with intravenous injection of a radiotracer one year after treatment (focal therapy)
    Where
    France
    Volunteers
    30 people
    Sponsor
    University Hospital, Toulouse
    Can I take part? ECETEP
  • Anorexia Nervosa

    Speech Groups for Children Living With a Sibling Who Suffers From Anorexia Nervosa

    • Recruiting
    • Age: 8 to 18 years
    • Observational study

    Anorexia nervosa (AN) is a complex mental disease with a huge impact on the patient's siblings life and well-being. Based on literature, group interventions for siblings of children suffering from a chronic disease could provide…

    Trial name
    EMA-FRaM (NCT06528158)
    Testing
    sibling group
    Where
    France
    Volunteers
    24 people
    Sponsor
    University Hospital, Toulouse
    Can I take part? EMA-FRaM
  • Obstructive Sleep Apnea Syndrome

    Predictive Factors for Occlusal Changes in Obstructive Sleep Apnea Treatment With Mandibular Advancement Appliance

    • Recruiting
    • Age: 18 years and older
    • Observational study
    • Medical device

    This research addresses obstructive sleep apnea syndrome (OSAS), affecting 6-12% of French adults, often treated with mandibular advancement devices (MADs).

    Trial name
    APNEAMOUVE (NCT06576310)
    Testing
    Mandibular Advancement Device
    Where
    France
    Volunteers
    118 people
    Sponsor
    University Hospital, Toulouse
    Can I take part? APNEAMOUVE
  • Carotid Web

    Familial Form of Carotid Web: a Doppler Ultrasound Study

    • Recruiting
    • Age: 18 to 65 years
    • Surgery or procedure

    There is no evidence of familial forms of carotid web. The aim of this study is to determine the prevalence of carotid web among relatives of patient with carotid web using carotid doppler ultrasound.

    Trial name
    Family-WEB (NCT06336083)
    Testing
    Doppler ultrasound
    Where
    France
    Volunteers
    90 people, healthy volunteers welcome
    Sponsor
    University Hospital, Toulouse
    Can I take part? Family-WEB
  • Heart Failure, Cardiac Surgery

    Discontinuation or Continuation of SGLT-2 Inhibitors Before Cardiac Surgery

    • Not yet recruiting
    • Age: 18 years and older
    • Phase 4

    SGLT-2 inhibitors are recommended treatments for managing heart failure patients. In cases of surgery, it is recommended to stop the treatment 3 days before surgery due to the risk of postoperative euglycemic diabetic…

    Trial name
    DISCO (NCT07766109)
    Testing
    treatment discontinuation, treatment continuation, ketone levels
    Where
    France
    Volunteers
    434 people
    Sponsor
    University Hospital, Toulouse
    Can I take part? DISCO
  • Aphasia, Stroke

    Effect of Anomia Rehabilitation Combined With Metacognitive Training in Patients With Chronic Vascular Aphasia

    • Recruiting
    • Age: 18 years and older
    • Lifestyle or therapy programme

    The postulate of this study is that rehabilitation combining linguistic and metacognitive training will result in a significant improvement in language performance correlated with changes in functional cerebral connectivity…

    Trial name
    METALEX (NCT06930131)
    Testing
    Semantic rehabilitation
    Where
    France
    Volunteers
    18 people
    Sponsor
    University Hospital, Toulouse
    Can I take part? METALEX
  • PARKINSON DISEASE (Disorder)

    Effect of Botulinum Toxin on Resting Tremor of the Refractory Upper Limb in Parkinsonians

    • Not yet recruiting
    • Age: 40 to 80 years
    • Phase 3

    Tremor is one of the most common symptoms in Parkinson Disease (PD), affecting almost 60% of patients. There is currently no specific treatment for tremor in PD, and 30% of patients develop drug-resistant tremor, making its…

    Trial name
    TOX PARK (NCT07822893)
    Where
    2 sites in France
    Volunteers
    39 people
    Sponsor
    University Hospital, Toulouse
    Can I take part? TOX PARK
  • Infusion of Ketamine in Severe Borderline Personality Disorder, Borderline Personality Disorder (BPD)

    Ketamine Infusion for Symptomatic Improvement in Severe Borderline Personality Disorder

    • Not yet recruiting
    • Age: 18 to 65 years
    • Phase 2
    • Injection or infusion

    The main objective of this pilot study is to evaluate at D9 the evolution of BPD symptoms' intensity(scale BSL-23) in severe BPD patients, after two Ketamine infusions (0.5mg/kg at H0 and H24).

    Trial name
    BorderKET (NCT07099534)
    Testing
    IV Ketamine (0.5 mg/kg) Infusion - Two Doses Administered 24 Hours Apart for Severe Borderline Personality Disorder
    Where
    France
    Volunteers
    38 people
    Sponsor
    University Hospital, Toulouse
    Can I take part? BorderKET

Completed, with results posted

All 2

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in